Opinion | April 17, 2026
Beyond beds and buildings: The quiet capital shift reshaping healthcare
The investment case for health technology in India is frequently overstated in one direction and understated in another
The investment case for health technology in India is frequently overstated in one direction and understated in another
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
The goal is to better support drug developers as programs move from laboratory research into clinical trials
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Paves the way for next-gen ultra-precise gas sensing
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Subscribe To Our Newsletter & Stay Updated
